@article{derquin:hal-02909552,
TITLE = {Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network},
AUTHOR = {Derquin, F. and Floquet, A. and Hardy-Bessard, A.C. and Edeline, J. and Lotz, J.P. and Alexandre, J. and Pautier, P. and Angeles, M.A. and Delanoy, N. and Lefeuvre-Plesse, C. and Cancel, M. and Treilleux, I. and Augereau, P. and Lavoue, V. and Kalbacher, E. and Berton Rigaud, D. and Selle, F. and Nadeau, C. and Gantzer, J. and Joly, F. and Guillemet, C. and Pomel, C. and Favier, L. and Abdeddaim, C. and Venat-Bouvet, L. and Provansal, M. and Fabbro, M. and Kaminsky, M.C. and Lortholary, A. and L{\'e}curu, F. and Coquard, I Ray and de La Motte Rouge, T.},
URL = {https://hal.science/hal-02909552},
JOURNAL = {Gynecologic Oncology},
PUBLISHER = {Elsevier},
VOLUME = {158},
NUMBER = {3},
PAGES = {666-672},
YEAR = {2020},
MONTH = Jul, DOI = {10.1016/j.ygyno.2020.06.491},
KEYWORDS = {Prognostic factors ; Rare malignant ovarian tumors ; Stage I ; TMRG},
PDF = {https://hal.science/hal-02909552/file/S0090825820323155.pdf},
HAL_ID = {hal-02909552},
HAL_VERSION = {v1},
}
Affichage BibTex